Literature DB >> 15872305

Human cytomegalovirus infection of a severe-burn patient: evidence for productive self-limited viral replication in blood and lung.

Klaus Hamprecht1, Mathias Pfau, Hans-Eberhard Schaller, Gerhard Jahn, Jaap M Middeldorp, Hans-Oliver Rennekampff.   

Abstract

To date, only seroepidemiological data are available on the role of human cytomegalovirus (HCMV) in patients with severe burns. We present the first longitudinal analysis of disseminated HCMV infection with a demonstration of self-limited productive viral replication identified in both the blood and lung of a burn patient.

Entities:  

Mesh:

Year:  2005        PMID: 15872305      PMCID: PMC1153747          DOI: 10.1128/JCM.43.5.2534-2536.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Cytomegalovirus infection in severely burned patients.

Authors:  J Seeman; R Konigová
Journal:  Acta Chir Plast       Date:  1976

2.  Unexplained fever in burn patients due to cytomegalovirus infection.

Authors:  G S Deepe; B G MacMillan; C C Linnemann
Journal:  JAMA       Date:  1982-11-12       Impact factor: 56.272

3.  Human cytomegalovirus infections in nonimmunosuppressed critically ill patients.

Authors:  A Heininger; G Jahn; C Engel ; T Notheisen; K Unertl; K Hamprecht
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

4.  Severe hemorrhage from cytomegalovirus rectal ulcers in a burned adult.

Authors:  J W Ng; A Y Chan
Journal:  Am J Gastroenterol       Date:  1987-07       Impact factor: 10.864

5.  Herpes simplex virus and cytomegalovirus infections in burned patients.

Authors:  R J Kagan; S Naraqi; T Matsuda; O M Jonasson
Journal:  J Trauma       Date:  1985-01

6.  The epidemiology of cytomegalovirus infection among patients with burns.

Authors:  J F Bale; G P Kealey; R M Massanari; R G Strauss
Journal:  Infect Control Hosp Epidemiol       Date:  1990-01       Impact factor: 3.254

7.  Susceptibility of thermally injured mice to cytomegalovirus infection.

Authors:  H Kobayashi; M Kobayashi; D N Herndon; R B Pollard; F Suzuki
Journal:  Burns       Date:  2001-11       Impact factor: 2.744

8.  Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections.

Authors:  J R Hamilton; J C Overall; L A Glasgow
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Cytomegalovirus infection in burn patients.

Authors:  G P Kealey; J F Bale; R G Strauss; R M Massanari
Journal:  J Burn Care Rehabil       Date:  1987 Nov-Dec

10.  Cytomegalovirus infection in a cyclosporine-treated burn patient: case report.

Authors:  J F Bale; G P Kealey; C L Ebelhack; C E Platz; J A Goeken
Journal:  J Trauma       Date:  1992-02
View more
  4 in total

1.  Herpesviradae infections in severely burned children.

Authors:  Paul Wurzer; Megan R Cole; Robert P Clayton; Gabriel Hundeshagen; Omar Nunez Lopez; Janos Cambiaso-Daniel; Raimund Winter; Ludwik K Branski; Hal K Hawkins; Celeste C Finnerty; David N Herndon; Jong O Lee
Journal:  Burns       Date:  2017-04-15       Impact factor: 2.744

Review 2.  Human herpes viruses in burn patients: A systematic review.

Authors:  Paul Wurzer; Ashley Guillory; Daryousch Parvizi; Robert P Clayton; Ludwik K Branski; Lars-P Kamolz; Celeste C Finnerty; David N Herndon; Jong O Lee
Journal:  Burns       Date:  2016-08-08       Impact factor: 2.744

3.  Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.

Authors:  Alexandra Heininger; Helene Haeberle; Imma Fischer; Robert Beck; Reimer Riessen; Frank Rohde; Christoph Meisner; Gerhard Jahn; Alfred Koenigsrainer; Klaus Unertl; Klaus Hamprecht
Journal:  Crit Care       Date:  2011-03-01       Impact factor: 9.097

Review 4.  Viral Infections in Burn Patients: A State-Of-The-Art Review.

Authors:  Jacek Baj; Izabela Korona-Głowniak; Grzegorz Buszewicz; Alicja Forma; Monika Sitarz; Grzegorz Teresiński
Journal:  Viruses       Date:  2020-11-17       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.